CTRI/2024/01/061627尚未招募3 期
EFFICACY OF N-ACETYL CYSTEINE IN ANTITUBERCULAR DRUG INDUCED HEPATOTOXICITY – A RANDOMISED CONTROL STUDY - NI
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient diagnosed with antitubercular drug induced hepatotoxicity.
- •Patients Age >18 year of either sex and meet the all / any of the following criteria:
- •(i) a rise of five times the upper limit of normal levels of serum AST and/or ALT
- •without symptom of hepatotoxicity.
- •(ii) a rise of two times the upper limit of normal level of serum bilirubin.
- •(iii) More than 3 times increase in AST and/or ALT levels together with the hepatitis
排除标准
- •1.History of alcoholism and known case of alcoholic liver disease.
- •2. Known case of HIV, HBV, HCV.
- •3. Liver injury due to drugs other than ATT.
- •4. Pregnant or breastfeeding women.
研究者
相似试验
已完成
不适用
EFFECTIVENESS OF N-ACETYL CYSTEINE AS AN ADD ON THERAPY IN NEGATIVE AND COGNITIVE SYMPTOMS OF SCHIZOPHRENIA, AN OPEN LABEL 24 WEEKS FOLLOW-UP RANDOMIZED CONTROL TRIACTRI/2021/10/037493Dr Sharon Narula70
进行中(未招募)
不适用
THERAPEUTIC EFFECTIIVENESS OF N-ACETYL-CYSTEINE AND ASCORBIC ACID IN PATIENTS WITH ALKAPTONURIA-OCHRONOSIS - Acetilcisteina-Ocronosi-SI/2009patient affected by alkaptonuria-ocronosisEUCTR2009-012707-26-ITAZIENDA OSPEDALIERA SENESE50
已完成
3 期
acetylcysteine in the treatment of diarrhea caused by rotavirusDiarrhea caused by rotavirus.A08.0Rotaviral enteritisIRCT20181208041882N13Yazd University of Medical Sciences64
已完成
不适用
use of acetyl cystein in prevention of anti-TB drug induced hepatitisdrug induced hepatits.Toxic liver disease with hepatic necrosisIRCT201205259855N1Arak University of Medical sciences
已完成
3 期
The effect of acetylcysteine and bromhexine on the improvement and prevention of hospitalization in outpatients with Covid-19IRCT20220302054167N1Hamedan University of Medical Sciences225
